Valion Bio raises $700,000 in preferred stock and warrant private placement
VBIO•Valion Bio raised $700,000 from 3i in a private placement on November 6, 2026, selling 700 shares of Series B preferred stock and warrants to buy 21,539 common shares at an initial exercise price of $0.5182 per share.
1. Placement details
Valion Bio raised $700,000 from 3i in a private placement on November 6, 2026. The sale included 700 shares of Series B Non-Voting Convertible Preferred Stock and Series B Warrants to purchase 21,539 common shares at an initial exercise price of $0.5182 per share.
2. Registration and deadline
The company will seek to register the underlying common shares within 30 days of closing, targeting effectiveness within 60 days. The deadline for additional closings under the Series B Preferred Purchase Agreement was extended to December 9, 2027.
